Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.

Author: BrownRandy, CollierElizabeth, HaramEric, HorstJulie, JacobsonNora, KimJee-Seon, KnudsenHannah K, MaddenLynn, MolfenterTodd, StarrSanford, ToyAlexander, Van EttenMark

Paper Details 
Original Abstract of the Article :
Overdoses due to non-medical use of prescription opioids and other opiates have become the leading cause of accidental deaths in the USA. Buprenorphine and extended-release naltrexone are key evidence-based pharmacotherapies available to addiction treatment providers to address opioid use disorder (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688699/

データ提供:米国国立医学図書館(NLM)

Expanding Opioid Use Disorder Treatment: A Workforce Development Oasis

The opioid epidemic is a vast and unforgiving desert, leaving a trail of suffering and loss in its wake. This study delves into a critical aspect of the fight against opioid use disorder (OUD) - expanding the workforce of prescribers for pharmacotherapy. The lack of available prescribers is a major barrier to accessing this life-saving treatment.

Building a Workforce Oasis: A Key to Combating the Opioid Crisis

The study proposes a workforce development intervention to increase the number of providers trained to prescribe buprenorphine and extended-release naltrexone. It highlights the need for targeted interventions to address specific barriers to provider participation, including concerns about reimbursement and confidence in treating OUD patients. This is a crucial step toward ensuring access to effective treatment.

A More Accessible Journey for Those Struggling with OUD

This research is a beacon of hope in the challenging landscape of OUD. Expanding the workforce of prescribers could mean more individuals with OUD having access to life-saving treatment, reducing the devastating impact of this epidemic. It could mean a less treacherous journey toward recovery for those seeking a way out of the desert.

Dr. Camel's Conclusion

This study is a testament to the tireless efforts of researchers to find solutions to the opioid crisis. By investing in workforce development, we can create a more accessible oasis of treatment and support for those struggling with OUD, leading them toward a brighter future.

Date :
  1. Date Completed 2018-07-02
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

29141653

DOI: Digital Object Identifier

PMC5688699

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.